Background: Creatine (Cr) supplementation has been established as an ergogenic aid in most individuals during anaerobic exercise. However, discrepancies exist in the data when using absolute dosing. Objective: The effects of five weeks of resistance training with relatively-dosed Cr followed by four weeks of resistance training after ceasing supplementation were determined. Methods: Resistance-trained men, 19 (CR = 9, PL = 10), ingested Cr or placebo for five weeks with resistance training. Participants ingested 0.3 g/kg lean body mass/day for one week, 0.075 g/kg lean body mass/day for four weeks, with a four-week wash out. Five muscle samples, six blood samples, and nine urine samples were collected. Separate two-way ANOVAs for each criterion variable were used employing an alpha level of ≤ 0.05. Results: A group x time interaction for increased total body mass for CR Day 1 and 64 (p = 0.03) and total lean mass for CR Day 1 and 64 (p = 0.01). Group x time interactions occurred for Cr supplementation increasing serum Cr at Day 4, 8, and 22 (p = 0.03), urinary Cr at Day 4 (p = 0.01), and total muscle Cr at Day 8 (p < 0.001), 22 (p = 0.003), and 36 (p < 0.001). No significant differences occurred for serum (p = 0.14) or urine (p = 0.15) creatinine. Conclusion: Elevated levels of urinary Cr demonstrate dosing could be reduced.
Introduction
Creatine (Cr) is a naturally-occurring amino acid derivative that is endogenously synthesized primarily in the liver from arginine, glycine, and methionine. It contributes to the generation of adenosine triphosphate (ATP), which is necessary for muscular contraction (Beasman et al.,1985) . Cr supplementation during resistance training has demonstrated varying effects on muscle mass and strength (Lanhers et al., 2015) . The increase of intramuscular Cr concentration following supplementation has demonstrated a considerable variability in humans, suggesting a potential responder effect (Greenhaff et al., 1994) . A typical Cr supplementation protocol, [loading phase of 20 g of Cr per day (4 x 5 g) for 3-7 days, a maintenance phase of 4-5 g per day for four weeks, and a wash out phase of four weeks before the cycle is restarted] has been verified to significantly increase intramuscular Cr and phophorylcreatine stores (Cooper et al., 2012; Hultman et al., 1996; Lemon 2002 ). However, ~160 mmol/kg dry mass appears to be the upper limit for total Flourishing Creativity & Literacy 28 intramuscular Cr concentration, and additional Cr is excreted in the urine (Greenhaff et al., 1994) .
Absolute doses are typically employed for Cr supplementation, but create a potential confounder because absolute doses elicit varying increases in serum and intramuscular Cr concentrations among individuals with different body masses. Hultman et al., (1996) suggested a relative loading dose of 0.3 g/kg body mass/day for 5-6 days, followed by a maintenance dose of 0.03 g/kg body mass/day to eliminate varied body masses as a confounder. Syrotuik and Bell (2004) examined a relative dosing strategy similar to the recommendation of Hultman et al., (1996) but observed a varied response in increased intramuscular Cr levels between individuals.
Therefore, the purpose of this study was two-fold and involved determining, in resistance-trained males, the effects of five weeks of resistance training in conjunction with a typical relative Cr dosing protocol followed by four weeks of resistance training after ceasing Cr supplementation on: 1) body composition and muscle strength, 2) whole-body Cr metabolism.
Methods

Participants
Nineteen apparently healthy, resistance-trained [regular, consistent resistance training (i.e., thrice weekly) for at least one year prior to the study], males between the ages of 18-23 completed the study. Participants were required to perform a leg press 1-RM of at least 2.5 times their body weight followed by at least 10 repetitions at 70% of their 1-RM during a familiarization session to be considered trained to participate (Coburn and Malek, 2012) . Participants were recruited from Baylor University and from the area surrounding Waco, TX, USA. Overall, 32 healthy males were recruited. Nine elected to abstain from the study and four elected to withdraw. As a result, 19 participants completed the study. Only participants considered as low risk for cardiovascular disease and with no contraindications to exercise as outlined by the American College of Sports Medicine (ACSM), who had not consumed any nutritional supplements (excluding multi-vitamins) one month prior, and not consumed Cr in six months prior to the study were allowed to participate. Approval to conduct to study was granted by the Baylor University Institutional Review Board for the Protection of Human Subjects in Research. All experimental procedures involved in the study conformed to the ethical consideration of the Declaration of Helsinki. Individuals interested in the study were interviewed by phone and those believed to meet eligibility criteria were invited to attend an entry/familiarization session. Participants were familiarized to the study protocol by verbal and written explanation and then read and signed a university-approved informed consent document. Potential participants then completed a medical history questionnaire and underwent a general physical examination. Eligible participants were given an appointment time to perform baseline/pre-supplementation assessments and underwent their first testing session within two weeks of familiarization.
Design
In a double-blind procedure, participants were randomly assigned to groups using a random number generator. Supplementation involved orally ingesting packets containing a powdered dextrose placebo [PL (AST Sports Science; Golden, CO, USA)] or Cr monohydrate [CR (AST Sports Science; Golden, CO, USA)]. After baseline testing procedures and lean body mass determination via DEXA, participants in the CR and PL group ingested their respective supplement at a relative daily dose of 0.3 g/kg lean body mass (» 17-20 g/day) for one week in the loading phase and immediately following the loading phase, a relative daily dose of 0.075 g/kg lean body mass (» 5-7 g/day), during the four-week maintenance phase. All groups ceased supplementation on Day 36 following the four-week maintenance phase, which was then followed by a four-week washout phase without supplementation.
For Cr monohydrate and maltodextrose, both supplements were HPLC certified to be 99% and 98% pure, as confirmed by the manufacturer. Supplements were ingested with water on an empty stomach at 8:00 am, 12:00 pm, 4:00 pm, and 8:00 pm each day during the loading phase (equal constituent dose). During the maintenance phase, the daily standardized supplement (one packet/day, contained whole daily dose) was ingested at 12:00 pm. Dextrose and Cr powders were comprised of similar mesh size, texture, taste, and appearance and prepared by an objective third-party company (AST Sport Science, Colorado Springs, CO, USA). Supplement packets for each participant were individually weighed on an analytical balance (Denver Instrument, Golden, CO, USA) to the nearest 1% of the prescribed dose, and appropriately blinded by a lab technician not involved in the study. Participants were provided with dose packets one week at a time, and required to present empty packets each week to receive the next week's supplement. At Day 22, participants' doses were adjusted based on any changes in lean mass. Compliance to the supplementation protocol was monitored by the return of empty supplement packets each week and verified verbally.
Strength Testing
Participants performed four one-repetition maximum (1-RM) tests on the angled leg press sled (Nebula, Columbus, OH, USA) at Day 0, 8, 36, 64 . Participants warmed-up by completing two sets of 8-10 repetitions at approximately 50% of the estimated 1-RM, with two minutes rest in between all sets. Participants completed three to five repetitions at approximately 75% of the estimated 1-RM. The weight was increased conservatively, and the participant attempted to lift the weight for one repetition. If successful, the participant rested for two minutes before attempting the next weight increment. This was continued until the participant failed to complete the lift (Schwarz et al., 2015) . For the 70% 1-RM evaluation during the familiarization session, participants were allowed to rest five minutes following the determination of their 1-RM.
Body Composition Measures and Dietary Recall
Total body mass (kg) was determined on a Detecto digital scale (Webb City, MO, USA). Total body water (extracellular and intracellular) was determined with bioelectrical impedance (Xitron 4200, San Diego, CA, USA). Percent body fat, fat mass, and lean mass (bone mass excluded) were determined using dual-energy x-ray absorptiometer (DEXA; Hologic Discovery, Bedford MA, USA). Body composition was assessed at each of the five testing sessions at Day 0, 8, 22, 36, and 64. Participants recorded their dietary intake for 24 hours prior to each of the five testing sessions. The diets were not standardized and participants were instructed not to change their dietary habits during the study. The 24-hour dietary recalls were evaluated with a dietary assessment software program (Food Processor, ESHA Research, Salem OR, USA) to determine the average daily caloric, protein, carbohydrate, and fat intakes for the duration of the study.
Resistance Training Protocol
Participants followed a periodized 4-day/week resistance-training program split into two upper-body and two lowerbody workouts/week, for nine weeks (Table 1) . For each exercise, participants performed three sets of 10 repetitions with as much weight as they could lift per set (~70 -80% of 1RM). If they could lift fewer than 10 repetitions, they were instructed to reduce the weight, and if they could lift more than 10 repetitions at a given weight, they were instructed to increase the weight. Participants rested no longer than three minutes between exercises and no longer than two minutes between sets. During the familiarization session, participants gave verbal confirmation of how to properly perform each exercise. For both upper-and lower-body workouts, the participants were only required to perform the same exercise from a particular group for the current workout, but were allowed to select a different exercise from each group during a subsequent workout at their discretion. Abdominal crunch was performed in sets of 25 repetitions.
Serum, Urine and Muscle Collection
Participants fasted for eight hours prior to donating blood and urine samples. Venous blood samples were collected from the antecubital vein into two 7.5 mL SST collection tubes and one 4 mL EDTA tube using a standard Vacutainer apparatus for serum and whole blood analysis, respectively. Blood samples taken in the serum tubes were allowed stand at room temperature for 15 minutes, centrifuged for 15 minutes at 2,000 rpm, and then the serum was removed and frozen at -80°C for later analysis. A total of six blood samples were obtained: Day 0, 4, 8, 22, 36, and 64. Urine samples were obtained in mid-stream into a 50 ml collection tube using a standard collection protocol. Samples were collected on Day 0, 4, 8, 15, 22, 29, 36, 50, and 64 . Urine samples were separated into 1 mL aliquots and frozen at -80° C for later analysis.
Percutaneous muscle biopsies (50-70 mg) were obtained from the middle portion of the vastus lateralis muscle of the dominant leg at the midpoint between the patella and the greater trochanter of the femur at a depth of one cm. For the subsequent four biopsies, tissue extraction occurred approximately in the same location as the initial biopsy by using the pre-biopsy scar, depth markings on the needle, and a successive incision that was made approximately one cm to the former from medial to lateral. Adipose tissue was trimmed from the muscle tissue and the sample was immediately flash-frozen in liquid nitrogen and subsequently stored at -80°C for later analysis. A total of five muscle samples were collected prior to the first dose of supplement Day 0, 8, 22, 36, and 64.
Serum, Urine and Muscle Cr Analysis
Urine, blood, and muscle tissue samples were analyzed for free Cr using the diacetyl/α-napthtol reaction (Gundlach et al., 1968) .Unmodified urine and serum samples were immediately ready for analysis, while muscle tissue samples required additional preparation. Muscle tissue samples (~10 mg) were dried overnight in a vacuum centrifuge (ThermoSavant Speed Vac, Waltham, MA, USA), then powdered at room temperature with mortar and pestle. Powdered muscle was weighed (0.5-3.0 mg) and then Cr was extracted in a 0.5 M perchloric acid/1 mM EDTA solution on ice for 15 minutes. The samples were then spun in a 4˚C centrifuge at 15,000 rpm for 5 minutes, and the supernatant was neutralized with 2.1 M KHCO3/0.3 M MOPS solution, after which the supernatant was prepared for analysis. Total Cr of muscle samples was determined by reaction with 6.94 mM α-napthtol and a 1:2500 dilution of diacetyl. The reaction was incubated for 15 minutes at room temperature in the dark, and color formation was detected at 520 nm with microplate reader (xMark, Bio-Rad, Hercules, CA, USA). The samples were run against a standard curve of known Cr concentrations and total muscle Cr concentrations were expressed relative to muscle dry mass. The coefficient of variation for this assay was 6.7%.
Urine and serum levels of creatinine were determined photometrically by a DADE Dimension RXL clinical chemistry analyzer (Dade-Behring, Inc., Newark, DE, USA). Quality control and calibration procedures were completed prior to all analyses using liquid assay multiqual (BIO-RAD, Hercules, CA, USA). For both assays, the coefficients of variation were less than 5%.
Statistical Analysis
Data were analyzed using univariate two-way repeated measures analysis of variance (ANOVA) with the Statistical Package for Social Sciences (SPSS Inc., Chicago, IL, USA). Comparisons of demographics and supplement intake were determined using an independent Student's t-test. The use of parametric analysis was determined by evaluating kurtosis for each variable. For the analyses of urine, blood, muscle, body composition, and strength, respective 2 x 9, 2 x 6, 2 x 5, 2 x 5, and 2 x 4 repeated measures ANOVAs were utilized. An a-priori power calculation showed that 10 participants per condition was adequate to detect a significant difference between conditions in the marker of muscle strength in response to resistance training, given a type I error rate of 0.05 and a power of 0.80. Data were considered significantly different when the probability of error was 0.05 or less. Significant within-intensity and within-time differences were determined using Fisher's Least Significant Difference post-hoc test. If within-group assumption of sphericity was violated using Mauchly's Test of Sphericity, the Greenhouse-Geisser correction factor was used to evaluate observed within-group F-ratios to protect against Type I error. When necessary, Cohen's d effect calculations were performed to determine the size and significance between groups, independent of group size.
Results
Demographics
Nineteen (CR = 9, PL = 10) completed the study with no significant difference between groups in age [R 20.1 (1.6) vs. In regard to compliance, CR and PL were 95.23 ±9.36 % and 93.74 ±8.82 % compliant to the resistance training program, respectively. For supplementation, CR and PL were 96.21 ±4.87 % and 94.69 ±3.98 % compliant, respectively, to the supplementation protocol.
Body Composition Measures
Body composition measures are presented in Table 2 . There was a group x time interaction for increases in total body mass Day 1 and 64 (p = 0.03) and lean mass at Day 1 and 64 (p = 0.01). There were no significant differences found between groups for total body water (p = 0.99), intracellular fluid (p = 0.44), extracellular fluid (p = 0.69), extracellular: intracellular ratio (p = 0.80), or extracellular: total body water ratio (p = 0.76).
Strength Measures and Dietary Intake
Strength measures are presented in Table 2 and dietary intake is presented in Table 3 . There was a significant main effect for leg press 1-RM to increase with time at Day 8, 36, and 64 (p = 0.001); however, there was no significant group x time interaction (p = 0.17). The overall average strength gain for both groups as determined by change in leg press 1-RM over the course of the study was 33.01 ± 23.29 kg. The strength gain for the CR group was 41.16 ± 26.90 kg compared to the PL group, which was 25.68 ± 17.77 kg. There was not a significant difference within or between groups in caloric intake (p = 0.45), protein (p = 0.61), carbohydrate (p = 0.63), or fat (p = 0.26) over the course of the study.
Urine, Serum, and Muscle Cr
There was no statistical difference observed in serum Crn (p = 0.14) nor urine Crn (p = 0.15) (Table 4) , but a significant group x time interaction for increased serum Cr in the CR group observed at Day 4, 8, 22 (p = 0.003) (Table 5) . However, a significant group x time interaction for increased urine Cr at Day 4, 8, 15, 22, 29, and 36 (p = 0.01) in the CR group was located. For total muscle Cr (Table 6 ), a significant group x time interaction for total muscle Cr existed demonstrating the CR group to be significantly increased at Day 8 (p = 0.001), 22 (p = 0.003), and 36 (p = 0.001).
Discussion
Strength Measures and Dietary Intake
The purpose of this study was to examine the effects of a relatively-dosed Cr monohydrate supplementation protocol on body composition, muscle strength, and whole-body Cr metabolism in resistance-trained males. Even though Cr supplementation significantly increased muscle Cr concentration, the current investigation failed to find any significant Cr-induced improvements in body composition and muscle strength. Data are expressed as means (± SD). * denotes a significant group x time interaction for increases in total body mass (p = 0.03) and lean mass (p = 0.01) at Day 1 and 64. There were no significant differences relative in total body water (p = 0.99). † denotes a significant main effect in both groups for leg press 1-RM to increase with time at Day 8, 36, and 64 (p = 0.001); however, there was no significant group x time interaction (p = 0.17).
There was a significant increase over time with resistance training in muscular strength for both groups. This strength increase in both groups was expected (Rawson and Volek, 2003) ; however, Cr supplementation failed to confer an additional strength increase beyond the PL group (Table 2) . Statistical analysis revealed a moderate effect size for the increase in leg press 1-RM in the CR group (d = 0.51). This suggests additional participants might have provided adequate statistical power to reveal a significantly greater strength gain in the CR group, which is in agreement with previous research (Earnest et al., 1995; Souza-Junior et al., 2011; Rawson and Volek, 2003) . The participants were instructed to maintain their normal mixed diets for the duration of the study, and there were no significant differences between-or within-groups throughout the course of the study for daily total caloric intake (Table 3) . Therefore, it is unlikely that dietary intake influenced the strength measures. It is feasible some participants did not comply fully with the resistance training protocol, despite indicating otherwise, or incorrectly reported weights lifted, potentially introducing inaccuracies. Previous studies have indicated similar consumption of Cr combined with resistance exercise significantly improves body composition and fat-free mass (Greenhaff, 1995; Rawson and Volek, 2003) . The results of the current investigation for total body mass and lean mass, both of which were significantly elevated in the CR group, were in agreement with prior research (Willoughby and Rosene, 2001) . A significant change in percent body fat was detected; however, a low to moderate effect size for a decrease in percent body fat in the CR group was observed (d = 0.33).
There was a significant increase in intracellular fluid and total body water in the CR group, while there was no significant change in intracellular and extracellular water, or the ratio between the two. Cr is an osmotically active compound, such that increases in total body Cr retention caused by supplementation should consequently produce an increase in water retention. Although, it should be noted that a loading phase of 25 g/d for 7 days followed by a maintenance phase of 5 g/d for 21 days resulted in increases in intramuscular Cr and total body water, without altering proportional fluid distribution (Powers et al., 2003) . In the current investigation when total body water was expressed relative to total body mass, the significant increase was not present. These findings are consistent with the previous study (Powers et al., 2003) , which found that similar Cr loading and maintenance increased total body water without altering overall fluid distribution.
The Cr supplementation was similar to previous studies demonstrating increases in serum and muscle Cr in response to Cr supplementation (Burke et al., 2003; Casey et al., 1996; Greenhaff et al., 1994; Hultman et al., 1996; Snow et al., 1998) . In the present study, the CR group consumed an average 18.8 g/day for a loading phase, followed by a maintenance phase of 4.77 g/day. Interestingly these doses are approximately the same as absolute doses of 20 g/day for loading and 5 g/day maintenance phases (Greenhaff et al., 1994; Preen et al., 2003) . Snow et al. (1998) provided a bolus dose of 30g of Cr for only 5 days showing elevated total muscle Cr, but failed to observe an improvement in 20-second cycle ergometer sprints. The current investigation observed similar increases in total muscle Cr despite utilizing a relative dose based on lean mass. However, unlike much of the previous research the current study examined intramuscular Cr during a four-week post-supplementation washout phase. Intramuscular Cr levels returned to near baseline levels at the end of the washout phase. The present data suggest that, in resistance-trained males, chronic supplementation of Cr at the dose provided (relative to kilogram of lean mass) during five weeks of resistance training is capable of increasing and subsequently maintaining elevations in muscle Cr.
Urine Cr and Crn
In prior investigations, a loading dosage of 0.1 g Cr/kg fat-free mass/day resulted in 46% of Cr ingested being excreted in the urine 24 hours post-supplementation, but no changes in Crn excretion (Burke et al., 2001; Greenhaff et al., 1994; Preen et al., 2003) . Comparatively in the current investigation, approximately three times that amount of Cr was ingested by our participants during the loading phase, and after three days of supplementation, urine Cr concentrations increased over 1000-fold from baseline levels, and remained similarly elevated after one week of supplementation (Table 4) . As a result, a significant increase in urinary Cr was observed; however, there was no significant increase in urinary Crn. These findings are consistent with previous studies showing increases in urinary Cr but not in urinary Crn (Powers et al., 2003; Syrotuik and Bell, 2004) . This suggests the supplementation dose of Cr was higher than the functional capacity to be metabolized, and was wasted via urinary excretion. Despite the supplementation dose based on lean mass measures to attempt to reduce this occurrence, considerable amounts of Cr were still essentially wasted. 
Serum and Muscle Cr and Crn
Serum Cr concentrations were significantly elevated from baseline after three and seven days of Cr supplementation, and at the end of the maintenance phase (Table 5) . A significant elevation in serum Cr was observed in the CR group. Conversely, there was no significant increase in serum Crn. Consistent with previous research (Robinson et al., 2000; Schedel et al., 1999) , these findings provide an indication that exogenous Cr supplementation effectively increased Cr concentration within the circulation, thereby augmenting the Cr pool that was available to the skeletal muscle for uptake. Combined with the intramuscular total Cr data (Table 6) , it can be postulated the exogenous Cr supplementation apparently saturated intramuscular Cr stores given the high levels of serum and urinary Cr. Furthermore, the overall Cr supplementation dose could be lowered given the high levels of urinary Cr. An investigation at lower relative supplementation doses of Cr in resistance-trained males could further clarify the dose response to elicit elevated intramuscular Cr stores with minimal excretion of Cr. The current investigation observed an average increase in total muscle Cr of ~ 30 mmol/kg dry weights in the CR group. Further examination of the individual data showed 10/11 participants would be classified as responders (Greenhaff et al., 1994) . That individual observed an increase of only 18 mmol/kg dry weight and thus would be considered a quasi-responder. Combined with the strength data, this suggests additional criteria to be classified as a true responder as opposed to simply total muscle Cr. Although not examined in the current investigation, individuals with a higher percentage of type II fibers have been suggested as an additional factor to an individual's responder status (Lemon, 2002) .
Data are expressed as means (±SD). * denotes a significant group x time interaction (p = 0.003) for total muscle Cr concentration existed in the CR group at Day 8, 22, and 36. 
Conclusion and Practical Applications
A relative supplementation dose of Cr should be utilized to maximize ergogenic benefits while minimizing excretion of extra Cr. Although, additional investigations should examine lower relative doses than 0.3 g/kg lean mass followed by four weeks 0.075 used in the current design to determine precise dosing strategies to maximize ergogenic benefits with minimal excretion or waste of Cr through urine. There are several limitations including the sample size was relatively small, but larger than in many published studies with a similar experimental design. The daily consumption of the supplement and weight training sessions were not directly monitored. Finally, it was assumed participants were truthful about their compliance with the resistance training and supplementation protocols and in not ingesting any additional nutritional supplements during the study. One week of Cr supplementation at 0.3 g/kg lean mass followed by four weeks 0.075 g/kg lean mass successfully elicited significant gains in total muscle Cr content, total body mass, lean mass, and total body water. Although resistance training increased muscle strength in both groups, Cr supplementation did not have an additive effect. Supplementation significantly elevated serum Cr levels and Cr excretion in the urine, indicating adaptive handling of exogenous Cr. The saturation of intramuscular Cr in combination with the serum and urine Cr data suggests that, in resistance-trained men, even an individualized, relatively-dosed Cr supplementation protocol creates high levels of Cr being excreted during the loading and maintenance phases.
